Cancer is a disease of aging and, as the world's population ages, the number of older
persons with cancer is increasing and will make up a growing share of the oncology …

Aim. The aim of this systematic review is to summarise all available data on the effect of a
geriatric evaluation on the multidisciplinary treatment of older cancer patients, focussing on …

The American Society of Clinical Oncology (ASCO) convened a subcommittee to develop
recommendations on improving the evidence base for treating older adults with cancer in …

Background Comorbidity is very common among patients with cancer. Multidisciplinary team
meetings (MDTs) are increasingly the context within which cancer treatment decisions are …

BACKGROUND Prior research has documented the under‐representation in clinical trials of
older patients with cancer. In part of a larger study to test the magnitude of these barriers to …

Abstract The European Society for Medical Oncology (ESMO) consensus conference on
mature B cell lymphomas and chronic lymphocytic leukaemia (CLL) was held on 20 June …

Objectives Oncologists can be one of the major barriers to older adult's participation in
research. Multiple studies have described academic clinicians' concerns for not enrolling …

We conducted a phase II study to assess activity and safety profile of bendamustine and
rituximab in elderly patients with untreated diffuse large B-cell lymphoma (DLBCL) who were …

Abstract Treatment guidelines are primarily based on randomized clinical trials (RCTs).
RCTs tend to some extent to exclude older adults despite the fact that physicians need …

Objective The G8 is a screening test to identify frail elderly patients with cancer. Objectives
were to design and evaluate the performance of alternative tests taking into account other …